PMID- 22245316 OWN - NLM STAT- MEDLINE DCOM- 20130121 LR - 20220318 IS - 1558-1497 (Electronic) IS - 0197-4580 (Print) IS - 0197-4580 (Linking) VI - 33 IP - 10 DP - 2012 Oct TI - Whole brain N-acetylaspartate concentration is conserved throughout normal aging. PG - 2440-7 LID - 10.1016/j.neurobiolaging.2011.12.008 [doi] AB - We hypothesize that normal aging implies neuronal durability, reflected by age-independent concentrations of their marker--the amino acid derivative N-acetylaspartate (NAA). To test this, we obtained the whole-brain and whole-head N-acetylaspartate concentrations (WBNAA and WHNAA) with proton magnetic resonance (MR) spectroscopy; and the fractional brain parenchyma volume (fBPV)--a metric of atrophy, by segmenting the magnetic resonance image (MRI) from 42 (18 male) healthy young (31.9 +/- 5.8 years old) and 100 (64 male, 72.6 +/- 7.3 years old) cognitively normal elderly. The 12.8 +/- 1.9 mM WBNAA of the young was not significantly different from the 13.1 +/- 3.1 mM in the elderly (p > 0.05). In contrast, both fBPV (87.3 +/- 4.7% vs. 74.8 +/- 4.8%) and WHNAA (11.1 +/- 1.7 mM vs. 9.8 +/- 2.4 mM) were significantly higher in the young (approximately 14%; p < 0.0001 for both). The similarity in mean WBNAA between 2 cohorts 4 decades of normal aging apart suggests that neuronal integrity is maintained across the lifespan. Clinically, WBNAA could be used as a marker for normal (hence, also abnormal) brain aging. In contrast, WHNAA and fBPV seem age-related suggesting that brain atrophy may occur without compromising the remaining tissue. CI - Copyright (c) 2012 Elsevier Inc. All rights reserved. FAU - Wu, William E AU - Wu WE AD - Department of Radiology, New York University School of Medicine, New York, NY, USA. FAU - Gass, Achim AU - Gass A FAU - Glodzik, Lidia AU - Glodzik L FAU - Babb, James S AU - Babb JS FAU - Hirsch, Jochen AU - Hirsch J FAU - Sollberger, Marc AU - Sollberger M FAU - Achtnichts, Lutz AU - Achtnichts L FAU - Amann, Michael AU - Amann M FAU - Monsch, Andreas U AU - Monsch AU FAU - Gonen, Oded AU - Gonen O LA - eng GR - R01 NS050520-05/NS/NINDS NIH HHS/United States GR - R01 EB001015-16/EB/NIBIB NIH HHS/United States GR - R56 NS050520-06A1/NS/NINDS NIH HHS/United States GR - R01 EB001015/EB/NIBIB NIH HHS/United States GR - EB01015/EB/NIBIB NIH HHS/United States GR - R01 NS050520/NS/NINDS NIH HHS/United States GR - R01 AG022374/AG/NIA NIH HHS/United States GR - NS050520/NS/NINDS NIH HHS/United States GR - P30 AG008051/AG/NIA NIH HHS/United States GR - R01 AG012101/AG/NIA NIH HHS/United States GR - R56 NS050520/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120114 PL - United States TA - Neurobiol Aging JT - Neurobiology of aging JID - 8100437 RN - 0 (Biomarkers) RN - 30KYC7MIAI (Aspartic Acid) RN - 997-55-7 (N-acetylaspartate) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Aging/*metabolism MH - Aspartic Acid/*analogs & derivatives/analysis/metabolism MH - Atrophy/metabolism MH - Biomarkers/analysis/metabolism MH - Brain/*metabolism/pathology MH - *Brain Chemistry MH - Female MH - Humans MH - Magnetic Resonance Spectroscopy/methods MH - Male MH - Middle Aged MH - Organ Size PMC - PMC3328687 MID - NIHMS343196 COIS- Disclosure statement The authors state that there are no actual or potential conflicts of interest related to this paper. EDAT- 2012/01/17 06:00 MHDA- 2013/01/23 06:00 PMCR- 2013/10/01 CRDT- 2012/01/17 06:00 PHST- 2011/03/21 00:00 [received] PHST- 2011/12/01 00:00 [revised] PHST- 2011/12/03 00:00 [accepted] PHST- 2012/01/17 06:00 [entrez] PHST- 2012/01/17 06:00 [pubmed] PHST- 2013/01/23 06:00 [medline] PHST- 2013/10/01 00:00 [pmc-release] AID - S0197-4580(11)00540-9 [pii] AID - 10.1016/j.neurobiolaging.2011.12.008 [doi] PST - ppublish SO - Neurobiol Aging. 2012 Oct;33(10):2440-7. doi: 10.1016/j.neurobiolaging.2011.12.008. Epub 2012 Jan 14.